Objective: While the upregulation of cytochrome P450 family 24 subfamily A member 1 (CYP24A1) gene expression has been reported in colon cancer, its role in tumorigenesis remains largely unknown. In this study, we aimed to investigate the involvement of CYP24A1 in Wnt pathway regulation via the nuclear factor kappa B (NF-kappa B) pathway. Methods: The human colon cancer cell lines HCT-116 and Caco-2 were subjected to stimulation with interleukin-6 (IL-6) as well as tumor necrosis factor alpha (TNF-alpha), with subsequent treatment using the NF-kappa B pathway-specific inhibitor ammonium pyrrolidinedithiocarbamate (PDTC). Furthermore, CYP24A1 expression was subjected to knockdown via the use of small interfering RNA (siRNA). Subsequently, NF-kappa B pathway activation was determined by an electrophoretic mobility shift assay, and the transcriptional activity of beta-catenin was determined by a dual-luciferase reporter assay. A mouse ulcerative colitis (UC)-associated carcinogenesis model was established, wherein TNF-alpha and the NF-kappa B pathway were blocked by anti-TNF-alpha monoclonal antibody and NF-kappa B antisense oligonucleotides, respectively. Then the tumor size and protein level of CYP24A1 were determined. Results: IL-6 and TNF-alpha upregulated CYP24A1 expression and activated the NF-kappa B pathway in colon cancer cells. PDTC significantly inhibited this increase in CYP24A1 expression. Additionally, knockdown of CYP24A1 expression by siRNA could partially antagonize Wnt pathway activation. Upregulated CYP24A1 expression was observed in the colonic epithelial cells of UC-associated carcinoma mouse models. Anti-TNF-alpha monoclonal antibody and NF-kappa B antisense oligonucleotides decreased the tumor size and suppressed CYP24A1 expression. Conclusion: Taken together, this study suggests that inflammatory factors may increase CYP24A1 expression via NF-kappa B pathway activation, which in turn stimulates Wnt signaling.